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Table 1: Sub-group analyses for HRQoL, Anxiety and Pain outcomes 
 HRQoL  








SMD (95% CI), I2 across 
conditions [No. meta-
analyses] 




0.11 (0.02, 0.20) I2 = 0% [9 
MAs] 
0.38 (0.15, 0.60),  I2 = 
65.9% [10 MAs] 
0.19 (0.08, 0.31),  I2 = 0% 
[2 MAs] 
Short 
(<12 months)  
0.29 (0.17, 0.42) I2 = 29.5% 
[15 MAs] 
0.27 (0.12, 0.43),  I2 = 
59.4% [26 MAs] 
0.32 (0.04, 0.59),  I2 = 
70.5% [8 MAs] 
Interaction 
effect 
p=0.06 p=0.48 p=0.62 
Age    
<18 years 0.20 (-0.15, 0.56),  I2 = 0% 
[3 MAs] 
0.37 (0.12, 0.62),  I2 = 
67.1% [7 MAs] 
Too heterogenous  I2 = 
86.5% [3 MAs] 
18-65 years  0.23 (0.14, 0.33),  I2 = 
39.4% [21 MAs] 
0.32 (0.15, 0.48) I2 = 63.6% 
[26 MAs] 
0.21 (0.12, 0.31),  I2 = 0% 
[6 MAs] 
>65 years  0.39 (-0.24, 1.02),  I2 = NA 
[1 MAs]* 
0.06 (-0.30, 0.43),  I2 = 0% 
[2 MAs] 
No data available* 
Interaction 
effect 
p=0.86 p=0.69 p=0.68 
CBT intensity    
High  0.21 (0.11, 0.32),  I2 = 0% 
[14 MAs] 
0.28 (0.15, 0.42),  I2 = 
54.3% [28 MAs] 
0.19 (0.01, 0.37),  I2 = 
17.5% [5 MAs] 
Low  0.23 (0.03, 0.42)  I2 = 68.1% 
[9 MAs] 
Too heterogenous  I2 = 
78.4% [8 MAs] 
Too heterogenous  I2 = 
84.1% [4 MAs] 
Interaction 
effect 
p=0.99 p=0.62 p=0.87 
Control 
group 
   
Active  0.09 (-0.01, 0.19),  I2 = 0% 
[8 MAs] 
0.19 (-0.00, 0.37),  I2 = 
48.6% [14 MAs] 
0.14 (-0.11, 0.38)  I2 = 
72.8% [3 MAs] 
Not active  0.31 (0.18, 0.45),  I2 = 
40.3% [14 MAs] 
0.37 (0.19, 0.55),  I2 = 
64.3% [20 MAs] 
0.59 (0.07, 1.11),  I2 = 
68.8% [5 MAs] 
Interaction 
effect 
p=0.04** p=0.24 p=0.86 
*older adult category not included in the meta-regression as not enough reviews identified within this category. 
** interaction between active and not active comparator groups (HRQoL) outcome significant at p<0.05 
 
 
